Live Breaking News & Updates on Global Regulatory Affairs Expert

Stay updated with breaking news from Global regulatory affairs expert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Annual General Meeting 2021


A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

United States , Plan Les Ouates , Merck Serono , Annette Clancy , Franciscus Verwiel , Petra Pharma , Brian Ocallaghan , Joyce Allaire , Ernest Loumaye , Edward Mathers , Shauna Dillon , Barbara Duncan , Jacky Vonderscher , Rafaele Elisabete Tordjman , Jim Irvin Healy , Catarina Edfj , Swiss Board School , University In Basel , Committee For The Fiscal Year , Compensation Committee , Committee For Orphan Medicinal Products , Public Accounting Firm , Office Contact , University Of St Gallen , Swiss Exchange , International Collaboration On Rare Diseases Orphan Drugs ,

ObsEva Annual General Meeting 2021 | MarketScreener


USD 253,235,253
USD 75,216,317
USD 328,451,570
4        
Elections to the Board of Directors and Election of the Chairman of the Board of Directors
The Board of Directors proposes the re-election of the following nominees for a term of one year expiring at the closing of the 2022 Annual General Meeting:
4.1        Re-election of Franciscus Verwiel as member and Chairman of the Board of Directors
4.2        Re-election of Annette Clancy as member of the Board of Directors
4.3        Re-election of Barbara Duncan as member of the Board of Directors
4.4        Re-election of Ernest Loumaye as member of the Board of Directors
4.5        Re-election of Edward Mathers as member of the Board of Directors ....

United States , Plan Les Ouates , Merck Serono , Annette Clancy , Franciscus Verwiel , Petra Pharma , Brian Ocallaghan , Joyce Allaire , Ernest Loumaye , Edward Mathers , Shauna Dillon , Barbara Duncan , Jacky Vonderscher , Rafaele Elisabete Tordjman , Jim Irvin Healy , Catarina Edfj , Swiss Board School , University In Basel , Committee For The Fiscal Year , Compensation Committee , Committee For Orphan Medicinal Products , Public Accounting Firm , Office Contact , University Of St Gallen , Swiss Exchange , International Collaboration On Rare Diseases Orphan Drugs ,

ObsEva Annual General Meeting 2021


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ObsEva Annual General Meeting 2021
ObsEva SAApril 22, 2021 GMT
Geneva, Switzerland and Boston, MA – April 22, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today published the invitation to its 2021 Annual General Meeting of Shareholders to be held on May 28, 2021 at 16:30 CEST at the company’s offices in Geneva, Chemin des Aulx 12, 3rd floor, 1228 Plan-les-Ouates, Switzerland.
 
 
1      Approval of the Annual Report, the Statutory Financial Statements and the Consolidated Financial Statements for Fiscal Year 2020
The Board of Directors proposes that the annual report, the statutory financial statements and the consolidated financial statements of ObsEva SA for fiscal year 2020 be approved. ....

United States , Plan Les Ouates , Sangartand Biopartners , Annette Clancy , Franciscus Verwiel , Brian Ocallaghan , Joyce Allaire , Ernest Loumaye , Shauna Dillon , Rafaele Elisabete Tordjman , Merck Serono , Petra Pharma , Jacky Vonderscher , Barbara Duncan , Edward Mathers , Catarina Edfj , Jim Irvin Healy , Biotechnologiein Strasburg , Swiss Board School , University In Basel , Committee For The Fiscal Year , Compensation Committee , Committee For Orphan Medicinal Products , Public Accounting Firm , Office Contact , University Of St Gallen ,

ObsEva SA: ObsEva Annual General Meeting 2021


ObsEva SA: ObsEva Annual General Meeting 2021
April 22
1
- ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women s reproductive health, today published the invitation to its 2021 Annual General Meeting of Shareholders to be held on May 28, 2021 at 16:30 CEST at the company s offices in Geneva, Chemin des Aulx 12, 3
rd floor, 1228 Plan-les-Ouates, Switzerland.
The agenda of the meeting will be as follows:
1
Statements
Consolidated Financial Statements for Fiscal Year 2020
The Board of Directors proposes that the annual report, the statutory financial statements and the consolidated financial statements of ObsEva SA for fiscal year 2020 be approved. ....

United States , Mecklenburg Vorpommern , Plan Les Ouates , Merck Serono , Annette Clancy , Franciscus Verwiel , Petra Pharma , Brian Ocallaghan , Joyce Allaire , Ernest Loumaye , Edward Mathers , Shauna Dillon , Barbara Duncan , Jacky Vonderscher , Rafaele Elisabete Tordjman , Jim Irvin Healy , Catarina Edfj , Swiss Board School , University In Basel , Committee For The Fiscal Year , University Of St Gallen , Compensation Committee , International Collaboration On Rare Diseases Orphan Drugs , Swiss Exchange , Cancer Drug Development Forum , Global Regulatory Affairs Expert ,